100.05
0.00
(0.00%)
As of 12:15:00 PM GMT+5:30. Market Open.
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Mihir Prakash Shah | MD & CEO | 6M | -- | -- |
| Mr. Binoy Baiju Shah | CFO & Director | 6M | -- | -- |
| Ms. Preet Vijay Kukreja | Company Secretary & Compliance Officer | -- | -- | -- |
Parnax Lab Limited
Bldg. No.8
104-107, Jogani Industrial Estate Chunabhatti Sion
Mumbai, 400022
India
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 12
Description
Parnax Lab Limited manufactures and sells pharmaceutical formulations in India and internationally. The company offers pharmaceutical products in the form of liquids, ointments, gels, creams, tablets, and capsules; and medicinal products. It provides cosmetic products; herbal; and nutraceutical products. The company was formerly known as Krishna-Deep Trade & Investments Limited and changed its name to Parnax Lab Limited in April 2012. The company was incorporated in 1982 and is headquartered in Mumbai, India.
Corporate Governance
Parnax Lab Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available